- My Alerts
- Go Ad-Free
-
My Account
In App
BSE Live
Jul 29, 16:01Prev. Close
25.68
Open Price
25.68
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
25.68 (6000)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of HPC Biosciences (in Rs. Cr.) | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 | |
| Diluted EPS (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 | |
| Cash EPS (Rs.) | 0.11 | 0.06 | 0.08 | 0.07 | 0.09 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 2.06 | 1.99 | 1.96 | 1.93 | 1.92 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 2.06 | 1.99 | 1.96 | 1.93 | 1.92 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.14 | 0.08 | 0.10 | 0.12 | 0.14 | |
| PBDIT/Share (Rs.) | 0.11 | 0.06 | 0.08 | 0.07 | 0.10 | |
| PBIT/Share (Rs.) | 0.07 | 0.02 | 0.04 | 0.01 | 0.04 | |
| PBT/Share (Rs.) | 0.07 | 0.02 | 0.04 | 0.01 | 0.04 | |
| Net Profit/Share (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 74.54 | 80.73 | 80.81 | 55.19 | 68.93 | |
| PBIT Margin (%) | 52.12 | 29.92 | 36.07 | 11.90 | 25.03 | |
| PBT Margin (%) | 52.12 | 29.92 | 36.07 | 11.90 | 25.03 | |
| Net Profit Margin (%) | 51.16 | 28.06 | 34.63 | 10.12 | 22.48 | |
| Return on Networth / Equity (%) | 3.56 | 1.06 | 1.76 | 0.63 | 1.65 | |
| Return on Capital Employed (%) | 3.62 | 1.13 | 1.84 | 0.75 | 1.84 | |
| Return on Assets (%) | 3.53 | 1.04 | 1.73 | 0.62 | 1.63 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 6.89 | 3.73 | 5.01 | 6.22 | 7.28 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 92.99 | 53.95 | 42.49 | 47.41 | 52.59 | |
| Quick Ratio (X) | 91.04 | 52.19 | 40.91 | 45.46 | 49.55 | |
| Inventory Turnover Ratio (X) | 4.17 | 1.49 | 1.81 | 2.11 | 1.85 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 413.86 | 413.87 | 501.68 | 647.12 | 774.78 | |
| EV/Net Operating Revenue (X) | 181.05 | 344.99 | 313.51 | 332.72 | 343.10 | |
| EV/EBITDA (X) | 242.86 | 427.30 | 387.93 | 602.85 | 497.73 | |
| MarketCap/Net Operating Revenue (X) | 181.18 | 345.24 | 313.67 | 332.75 | 343.14 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 12.61 | 13.07 | 16.01 | 21.02 | 25.33 | |
| Price/Net Operating Revenue | 181.22 | 345.54 | 313.87 | 332.92 | 343.35 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
